MetLife Investment Advisors LLC boosted its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 45,170 shares of the medical instruments supplier’s stock after acquiring an additional 148 shares during the quarter. MetLife Investment Advisors LLC owned about 0.06% of West Pharmaceutical Services worth $4,428,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the business. MML Investors Services LLC raised its position in West Pharmaceutical Services by 23.0% in the fourth quarter. MML Investors Services LLC now owns 3,706 shares of the medical instruments supplier’s stock worth $363,000 after acquiring an additional 694 shares in the last quarter. Squarepoint Ops LLC raised its position in West Pharmaceutical Services by 145.4% in the fourth quarter. Squarepoint Ops LLC now owns 36,075 shares of the medical instruments supplier’s stock worth $3,536,000 after acquiring an additional 21,375 shares in the last quarter. Suntrust Banks Inc. raised its position in West Pharmaceutical Services by 4.0% in the fourth quarter. Suntrust Banks Inc. now owns 41,525 shares of the medical instruments supplier’s stock worth $4,071,000 after acquiring an additional 1,614 shares in the last quarter. 1832 Asset Management L.P. raised its position in West Pharmaceutical Services by 0.3% in the fourth quarter. 1832 Asset Management L.P. now owns 878,420 shares of the medical instruments supplier’s stock worth $86,102,000 after acquiring an additional 2,400 shares in the last quarter. Finally, Two Sigma Advisers LP raised its position in West Pharmaceutical Services by 33.9% in the fourth quarter. Two Sigma Advisers LP now owns 2,500 shares of the medical instruments supplier’s stock worth $245,000 after acquiring an additional 633 shares in the last quarter. Hedge funds and other institutional investors own 92.93% of the company’s stock.
Separately, Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research report on Saturday, January 12th.
Shares of West Pharmaceutical Services stock opened at $103.67 on Friday. The company has a current ratio of 3.15, a quick ratio of 2.40 and a debt-to-equity ratio of 0.14. West Pharmaceutical Services Inc. has a 52 week low of $82.74 and a 52 week high of $125.09. The stock has a market capitalization of $7.69 billion, a price-to-earnings ratio of 36.89, a price-to-earnings-growth ratio of 3.29 and a beta of 1.25.
West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, February 14th. The medical instruments supplier reported $0.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.01. The firm had revenue of $422.50 million for the quarter, compared to analysts’ expectations of $432.38 million. West Pharmaceutical Services had a return on equity of 15.89% and a net margin of 12.05%. West Pharmaceutical Services’s revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the business posted $0.64 EPS. As a group, analysts predict that West Pharmaceutical Services Inc. will post 2.85 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Wednesday, April 17th will be paid a $0.15 dividend. The ex-dividend date of this dividend is Tuesday, April 16th. This represents a $0.60 dividend on an annualized basis and a yield of 0.58%. West Pharmaceutical Services’s dividend payout ratio is currently 21.35%.
COPYRIGHT VIOLATION WARNING: This news story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2019/03/24/metlife-investment-advisors-llc-raises-holdings-in-west-pharmaceutical-services-inc-wst.html.
West Pharmaceutical Services Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
Recommended Story: What is Compound Interest?
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.